Incidence of gastroduodenal ulcers during treatment with celecoxib or diclofenac: pooled results from three 12‐week trials in Chinese patients with osteoarthritis or rheumatoid arthritis

Abstract

In Asian patients with minimal significant risk factors, treatment with celecoxib was associated with a modest but significantly reduced incidence of gastric ulcers at the end of 12 weeks.